Hiergeist Andreas, Gläsner Joachim, Reischl Udo, Gessner André
Andreas Hiergeist, PhD, and Joachim Gläsner, PhD, are senior scientists at the Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Germany. Udo Reischl, PhD, is Head of Molecular Diagnostics and an associate professor for Medical Microbiology; and André Gessner, MD, PhD, is Director of the Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Germany.
ILAR J. 2015;56(2):228-40. doi: 10.1093/ilar/ilv017.
Analyzing human as well as animal microbiota composition has gained growing interest because structural components and metabolites of microorganisms fundamentally influence all aspects of host physiology. Originally dominated by culture-dependent methods for exploring these ecosystems, the development of molecular techniques such as high throughput sequencing has dramatically increased our knowledge. Because many studies of the microbiota are based on the bacterial 16S ribosomal RNA (rRNA) gene targets, they can, at least in principle, be compared to determine the role of the microbiome composition for developmental processes, host metabolism, and physiology as well as different diseases. In our review, we will summarize differences and pitfalls in current experimental protocols, including all steps from nucleic acid extraction to bioinformatical analysis which may produce variation that outweighs subtle biological differences. Future developments, such as integration of metabolomic, transcriptomic, and metagenomic data sets and standardization of the procedures, will be discussed.
分析人类以及动物的微生物群组成已越来越受到关注,因为微生物的结构成分和代谢产物从根本上影响宿主生理学的各个方面。最初,探索这些生态系统主要依赖于培养方法,而高通量测序等分子技术的发展极大地增加了我们的知识。由于许多微生物群研究基于细菌16S核糖体RNA(rRNA)基因靶点,至少在原则上,它们可以进行比较,以确定微生物群组成在发育过程、宿主代谢、生理学以及不同疾病中的作用。在我们的综述中,我们将总结当前实验方案中的差异和陷阱,包括从核酸提取到生物信息分析的所有步骤,这些步骤可能产生的变异超过了细微的生物学差异。还将讨论未来的发展,如代谢组学、转录组学和宏基因组数据集的整合以及程序的标准化。